RN
Ramesh Narsinhbhai Patel
About Ramesh Narsinhbhai Patel
Data last updated:
Ramesh Narsinhbhai Patel is a Designated Partner at Xender Biopharma & Research Llp (since 2016). The companies operate in Pharma and Infrastructure and Utilities. Earlier, Ramesh Narsinhbhai Patel was a Director at Orient Procon Private Limited (2012–2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Xender Biopharma & Research Llp AAF-8957 | Designated Partner | 10 Mar 2016 | 2016 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Orient Procon Private Limited U45201GJ2012PTC071128 | Director | 16 Jul 2012 | 2012 | ₹1.07 Cr (FY 2016) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ramesh Narsinhbhai Patel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chiragkumar Nagarbhai Patel | 07454061 | Xender Biopharma & Research Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramesh Narsinhbhai Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramesh Narsinhbhai Patel
Ramesh Narsinhbhai Patel currently holds 1 directorship: Xender Biopharma & Research Llp (Designated Partner, since 10 Mar 2016).
Ramesh Narsinhbhai Patel was first appointed on 16 Jul 2012 as Director at Orient Procon Private Limited. The most recent appointment on record is 10 Mar 2016 at Xender Biopharma & Research Llp.
Ramesh Narsinhbhai Patel held 1 earlier board appointment: Orient Procon Private Limited (Director, 16 Jul 2012 to 01 Oct 2016).
The current boards of Ramesh Narsinhbhai Patel's companies include Chiragkumar Nagarbhai Patel (Xender Biopharma & Research Llp).